Evidence map›Paper›PMID 36561145›Full record

ArticleFrontiers in chemistry2022

Efficient catalytic degradation of methylene blue by a novel Fe

Jian Li, Yufei Wang, Fanhui Guo, Juan Chen, Jinxi Wang, Xiaoyong Fan, Baoning Li, Santosh Kumar Verma, Qingbo Wei, Long Yan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jian LiSchool of Chemical Engineering and Technology, National Engineering Research Center of Coal Preparation and Purification, China University of Mining and Technology, Xuzhou, China.
Yufei WangSchool of Chemical Engineering and Technology, National Engineering Research Center of Coal Preparation and Purification, China University of Mining and Technology, Xuzhou, China.
Fanhui GuoSchool of Chemical Engineering and Technology, National Engineering Research Center of Coal Preparation and Purification, China University of Mining and Technology, Xuzhou, China.
Juan ChenSchool of Chemical Engineering and Technology, National Engineering Research Center of Coal Preparation and Purification, China University of Mining and Technology, Xuzhou, China.
Jinxi WangSchool of Chemical Engineering and Technology, National Engineering Research Center of Coal Preparation and Purification, China University of Mining and Technology, Xuzhou, China.
Xiaoyong FanSchool of Chemistry and Chemical Engineering, Yulin University, Yulin, China.
Baoning LiSchool of Chemistry and Chemical Engineering, Yulin University, Yulin, China.
Santosh Kumar VermaSchool of Chemistry and Chemical Engineering, Yulin University, Yulin, China.
Qingbo WeiSchool of Chemistry and Chemical Engineering, Yan'an University, Yan'an, China.
Long YanSchool of Chemistry and Chemical Engineering, Yulin University, Yulin, China.
Jianjun WuSchool of Chemical Engineering and Technology, National Engineering Research Center of Coal Preparation and Purification, China University of Mining and Technology, Xuzhou, China.
Yulin University · CNChina University of Mining and Technology · CNYan'an University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a novel three-dimensional photoelectric system was designed and constructed for the degradation of methylene blue (MB)

Indexed as

catalytic degradationmethylene bluephotoelectric systemthree-dimensional Fe3+TiO2@CGSwaster water treament

Identifiers

PMID36561145
PMCPMC9763565
OpenAlexW4311706255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.